refers to the clinically significant distress that arises when a child's experienced gender is incongruent with the sex assigned at birth, and the diagnosis sits at the intersection of developmental psychopathology, family systems work, and one of the most contested areas in contemporary psychiatry. The places the condition in its own chapter and provides a child-specific criterion set distinct from the adolescent and adult criteria, reflecting how identity, behavior, and distress present differently before puberty. Most prepubertal children referred to specialty clinics do not go on to identify as transgender in adolescence, but a substantial minority do, and predicting trajectory at the individual level remains unreliable. Clinical care centers on careful diagnostic assessment, treatment of co-occurring psychopathology, family-focused psychosocial support, and decisions about that are reversible by nature but psychologically consequential. Medical interventions such as puberty suppression and gender-affirming hormones are not used in prepubertal children; they enter the conversation only at or after Tanner stage 2. Bottom line: the prepubertal task is to relieve distress, support development, treat comorbidity, and avoid premature certainty in either direction.
Population estimates for childhood gender dysphoria are unstable because case ascertainment, diagnostic thresholds, and willingness to disclose have all shifted markedly over the past decade. Specialty referrals have risen sharply in most Western countries, with a relative shift toward natal-female presentations among older children and adolescents.
Prevalence
- Prepubertal prevalence of Gender Dysphoria meeting full DSM-5-TR criteria is estimated at well under 1%, with most population surveys reporting figures between 0.1% and 1.3% depending on whether the question captures gender variance, gender-incongruent identity, or diagnosable distress.[1-2]
- Self-reported without distress is more common in school-age children than diagnosable dysphoria and should not be conflated with it.[1]
Referral trends
- Referrals to specialty gender clinics in the United Kingdom, the Netherlands, Sweden, and the United States rose more than tenfold between roughly 2010 and 2020 before stabilizing or declining in several jurisdictions.[3-4]
- Historical case series in prepubertal samples skewed natal-male; contemporary referrals, particularly in the peripubertal range, skew natal-female.[3-4]
Comorbidity
- Co-occurring is overrepresented in clinic-referred children with gender dysphoria, with prevalence estimates ranging from roughly 6% to 26% across cohorts compared with about 1-2% in the general population.[5-6]
- , depressive disorders, and are each more common in referred samples than in age-matched peers.[5,7]
- Self-harm and suicidal ideation are elevated relative to peers, particularly in older children approaching puberty, though absolute completed-suicide rates remain low.[7-8]
Risk factors
No single biological, psychological, or social mechanism explains gender dysphoria in children. Current models are integrative and explicitly developmental, framing gender identity as the product of prenatal and postnatal neurobiological influences interacting with cognitive development, socialization, and self-categorization.
Neurobiology
- Prenatal androgen exposure influences sex-typed play behavior, with girls with classical showing higher rates of masculine-typed play and modestly elevated rates of gender-variant identification compared with unaffected siblings.[9]
- Structural and functional neuroimaging studies in adolescents and adults with gender dysphoria have reported small group-level differences in white-matter microstructure, cortical thickness, and hypothalamic activation patterns, but findings are inconsistent and have limited applicability to prepubertal children.[10]
- No imaging or laboratory marker has diagnostic utility at the individual level.[10]
Genetics
- Twin studies suggest a modest heritable contribution to gender identity and gender-variant behavior, with monozygotic concordance higher than dizygotic concordance but well below unity.[11]
- Candidate-gene work on androgen receptor and estrogen receptor polymorphisms has been inconsistent and is not clinically actionable.[11]
Developmental and psychosocial factors
- Gender identity in typically developing children consolidates between roughly ages 3 and 7, with most children expressing a stable identity by school age.[12]
- Family responses, peer environment, and cultural context shape the expression of gender variance but are not, in current models, considered sufficient causes of dysphoria.[12]
- The relationship between autism spectrum traits and gender variance is the subject of active research, with hypotheses ranging from shared neurodevelopmental substrate to autism-specific cognitive styles influencing identity formation; mechanism remains uncertain.[6]
DSM-5-TR provides a child-specific criterion set distinct from the adolescent and adult set, reflecting the developmental reality that prepubertal children typically express identity through behavior, play preference, and stated identity rather than through anatomic discomfort. The diagnosis requires both incongruence and distress or impairment; gender-variant behavior alone is not a disorder.[13]
DSM-5-TR Criterion A (children)
- A marked incongruence between experienced or expressed gender and assigned gender, lasting at least six months, manifested by at least six of the following, one of which must be the first.[13]
- A strong desire to be of the other gender, or insistence that one is the other gender.[13]
- In natal boys, a strong preference for cross-dressing or simulating female attire; in natal girls, a strong preference for wearing only typically masculine clothing and strong resistance to typically feminine attire.[13]
- A strong preference for cross-gender roles in make-believe play or fantasy play.[13]
- A strong preference for toys, games, or activities stereotypically associated with the other gender.[13]
- A strong preference for playmates of the other gender.[13]
- In natal boys, a strong rejection of typically masculine toys, games, and activities; in natal girls, a strong rejection of typically feminine toys, games, and activities.[13]
- A strong dislike of one's sexual anatomy.[13]
- A strong desire for the primary or secondary sex characteristics that match one's experienced gender.[13]
DSM-5-TR Criterion B
- The condition is associated with clinically significant distress or impairment in social, school, or other important areas of functioning.[13]
Specifiers
- With a disorder of sex development: a concurrent congenital condition affecting sex differentiation (for example, congenital adrenal hyperplasia or androgen insensitivity).[13]
- Posttransition specifier is not applicable to the child diagnosis; it is reserved for adolescents and adults who have completed at least one gender-affirming medical intervention.[13]
ICD-11 differences
- replaced "gender identity disorder of childhood" with and moved it out of the mental disorders chapter into the new chapter on conditions related to sexual health.[14]
- ICD-11 does not require distress for the diagnosis, a deliberate departure from DSM-5-TR that has drawn criticism on both clinical and conceptual grounds.[14]
- The depathologization framing of ICD-11 has practical implications for insurance coding, research case definitions, and cross-jurisdictional comparison.[14]
Prepubertal gender dysphoria presents through identity statements, sustained cross-gender preferences across multiple domains, and distress that is often most visible in contexts where gender is enforced — bathrooms, gym class, formal dress codes, or family events. Severity ranges from quiet, situational discomfort to persistent insistence and refusal to participate in activities perceived as gender-incongruent.
Symptom clusters
- Identity statements: persistent assertions over months to years that the child is, or wishes to be, the other gender, with the wording often shifting from "I want to be" toward "I am" as identity consolidates.[15]
- Behavioral preferences: cross-gender clothing, play, peer choice, and roles in pretend play; isolated tomboy or feminine-boy behavior without identity-level claims does not meet criteria.[13,15]
- Anatomic distress: a smaller proportion of prepubertal children verbalize dislike of primary sex characteristics or expressed wishes for the anatomy of the other sex; when present, this is clinically weighty.[13]
- Functional impact: school avoidance around gendered activities, refusal of gendered clothing, distress at family naming or pronoun use, and withdrawal from peers.[15]
Course features
- Onset is typically early, with sex-typed behavioral preferences observable in the preschool years; clinically significant dysphoria usually becomes recognizable between ages 4 and 8.[15-16]
- Trajectories diverge around puberty: in older follow-up cohorts of clinic-referred children, the majority did not continue to experience gender dysphoria into adolescence, while a substantial minority did and a subset went on to adult gender-affirming care.[16-17]
- Contemporary cohorts referred at older ages, with more consistent and insistent presentations, appear to show higher rates of persistence than the historical samples, although follow-up data are still maturing.[17]
Red flags warranting careful evaluation
- Onset of dysphoric identity claims tightly coupled to social contagion concerns (for example, a cluster of peers transitioning concurrently) should prompt broader differential assessment rather than reflexive affirmation or dismissal.[18]
- Co-occurring rigid or obsessional thinking, marked autistic features, or active psychotic symptoms should be assessed before assuming a stable gender-dysphoria framework.[6,18]
- Marked anatomic distress in a young child, particularly with self-injurious behavior toward primary sex characteristics, is a safety concern requiring urgent assessment.[15]
The differential is broader than it first appears because gender-variant behavior, identity exploration, and dysphoria can co-occur with — or be mimicked by — several psychiatric, developmental, and medical conditions. The clinical task is not to choose between gender dysphoria and another diagnosis but to clarify what is present and treat what is treatable.
Psychiatric and developmental
- Gender-nonconforming behavior without dysphoria: common, non-pathologic, and does not meet DSM-5-TR criteria; conflating the two leads to overdiagnosis.[13]
- Transvestic disorder: not diagnosed in prepubertal children and is characterized by sexual arousal to cross-dressing, a distinct phenomenology.[13]
- : focused on perceived defects in appearance rather than incongruence between gender identity and assigned sex.[13]
- with gender-themed : identity claims feel ego-dystonic and intrusive rather than ego-syntonic, often with classical OCD features elsewhere.[19]
- Autism spectrum disorder: rigid interests, restricted preferences, and atypical social cognition can shape gender-related claims; ASD and gender dysphoria can also genuinely co-occur.[6]
- Early-onset psychotic disorders: identity claims arising in the context of delusional or disorganized thought require separate evaluation; rare but consequential.[19]
- Trauma- and stressor-related disorders: chronic abuse or family disruption can produce identity disturbance that is not gender dysphoria proper.[19]
Medical and endocrine mimics
- Disorders of sex development including congenital adrenal hyperplasia, partial androgen insensitivity, and 5-alpha-reductase deficiency can produce ambiguous genitalia or atypical pubertal development and warrant pediatric endocrinology involvement.[9]
- Premature or precocious puberty can drive distress that is sometimes misread as gender dysphoria, especially when secondary sex characteristics appear at an age the child finds unwelcome.[20]
| Feature | Gender dysphoria of childhood | Gender nonconformity | OCD with gender-themed obsessions | ASD with gender-related interests |
|---|---|---|---|---|
| Identity claim | Insistent, persistent, consistent across settings | Absent or transient | Intrusive, distressing, ego-dystonic | Variable; may shift with interest pattern |
| Duration | At least 6 months | Variable, often situational | Waxes/wanes with OCD course | Tracks with circumscribed-interest pattern |
| Distress | Required for diagnosis | Typically absent | Present but anxiety-toned | Variable; often distress from inflexibility |
| Associated features | Anatomic distress, cross-gender preferences across domains | Single-domain preferences without identity claim | Other obsessions/, ritual checking | Restricted/repetitive behaviors, sensory features |
| First-line management | Psychosocial assessment, family work, treat comorbidity | Reassurance, monitoring | CBT with | Standard ASD supports plus gender assessment |
Assessment is multi-session, developmentally calibrated, and explicitly biopsychosocial. The clinician is gathering enough information to confirm or refute the diagnosis, identify comorbidity, characterize family dynamics, and surface safety concerns — not to predict trajectory, which cannot be done reliably at the individual level.[18]
Interview structure
- Separate developmentally appropriate interviews with the child, each parent or caregiver, and the family together; observe play with younger children rather than relying on verbal report alone.[18,21]
- Explore the history of gender expression and identity claims: when they began, how they have evolved, in what contexts they are strongest, and what language the child uses spontaneously.[18,21]
- Assess associated distress directly: anatomy, bathrooms, clothing, peer interactions, school, and family events.[18,21]
- Screen for trauma, bullying, peer victimization, and minority stress as both contributors to and consequences of presentation.[7-8]
Mandatory history elements
- Developmental history including milestones, sex-typed play, social communication, sensory features, and prior psychiatric assessment.[18]
- Pubertal status and signs of impending puberty; Tanner staging is the critical anchor for any medical-intervention discussion later in adolescence.[22]
- Family psychiatric and medical history, including disorders of sex development and family attitudes toward gender variance.[18]
- Safety review: suicidal ideation, non-suicidal self-injury, anatomic-directed self-harm, and exposure to violence or rejection.[7-8]
Physical exam and laboratory considerations
- Routine physical examination is appropriate; intrusive genital examination is not indicated in the psychiatric assessment of a prepubertal child without a specific clinical question.[22]
- Endocrine evaluation is reserved for children with signs of a disorder of sex development, atypical pubertal timing, or planned medical intervention; karyotype and hormonal studies are not part of a routine prepubertal psychiatric workup.[22]
- Laboratory and imaging investigations should be driven by differential considerations rather than by the gender-dysphoria diagnosis itself.[22]
Rating scales and instruments
- The and the parent-report are validated instruments for characterizing severity and tracking change over time.[23]
- The has child and adolescent forms used in clinical and research settings; psychometric performance is reasonable but cutoffs do not substitute for diagnostic interview.[23]
- Routine comorbidity screening with broad-band instruments such as the and disorder-specific scales (PHQ-A, SCARED, rating scales, autism screening) is standard practice.[18,21]
What not to order
- Brain MRI, EEG, and genetic testing are not indicated to "confirm" gender dysphoria; ordering them risks medicalizing identity and exposing the child to unnecessary investigation.[10,22]
Care for prepubertal children with gender dysphoria centers on psychosocial support, family work, and treatment of comorbidity. No pharmacologic agent treats gender dysphoria in this age group, and medical interventions affecting puberty or secondary sex characteristics are not used before Tanner stage 2.[21,24]
Pharmacotherapy
- No medication has an indication for gender dysphoria in prepubertal children; pharmacotherapy is directed at comorbid anxiety, depression, ADHD, or OCD when present and treated according to standard disorder-specific guidelines.[21]
- Limited evidence suggests that treatment of comorbid mood and anxiety disorders is commonly recommended in this population using agents such as fluoxetine 10-20 mg PO QD or sertraline 25-50 mg PO QD when SSRI treatment is clinically indicated, with standard pediatric monitoring.[25]
- Puberty suppression with is not used in prepubertal children; eligibility begins at Tanner stage 2 under specialist endocrine care and is addressed in adolescent-focused guidelines and articles.[24,26]
Psychotherapy
- Evidence suggests that supportive, developmentally tailored psychotherapy aimed at reducing distress, treating comorbidity, and supporting family functioning is the mainstay of prepubertal care.[21,27]
- Family-based interventions that reduce parental rejection and conflict over gender expression are associated with better mental-health outcomes in observational data, although causal interpretation is limited.[7,27]
- is appropriate for co-occurring anxiety, depression, and OCD using standard pediatric protocols; CBT is not a treatment for gender identity itself, and approaches aimed at changing a child's gender identity (so-called conversion or reparative practices) are not recommended and are increasingly prohibited by law in multiple jurisdictions.[21,27-28]
- Watchful waiting — active monitoring with psychosocial support, family work, and deferral of irreversible decisions — has historically been a mainstream approach, particularly given the high desistance rates observed in older prepubertal cohorts; its appropriateness in the contemporary referral population is actively debated.[16-18]
Neuromodulation
- Neuromodulation has no role in the treatment of gender dysphoria at any age.[1-2]
Adjunctive
- Social transition — changes in name, pronouns, clothing, and hairstyle without medical intervention — is reversible by nature but psychologically meaningful, and decisions are individualized in collaboration with the child and family.[21,29]
- Limited evidence suggests social transition in prepubertal children is associated with improved short-term mental health outcomes in some observational cohorts, while other cohorts and follow-up data raise questions about its influence on persistence of identity into adolescence; high-quality comparative data are lacking.[29-30]
- School-based supports, anti-bullying interventions, and access to safe bathrooms and changing facilities are commonly recommended.[7,21]
- Peer-support and family-support groups can reduce isolation for both children and parents, though evidence for specific outcomes is limited.[21]
| Intervention | Evidence base/Comparator | Benefits | Harms | Certainty | Notes |
|---|---|---|---|---|---|
| Psychosocial support and family-focused care | Observational cohorts, guideline consensus (WPATH SOC-8, Endocrine Society, AACAP) | Reduced distress, improved family functioning, treatment of comorbidity | Minimal direct harms; opportunity cost if it delays needed treatment of comorbid conditions | moderate | Mainstay of prepubertal care; specific manualized protocols are limited |
| Watchful waiting with active monitoring | Historical follow-up cohorts (Steensma, Wallien, Drummond, Singh) | Avoids premature medical intervention; permits identity to consolidate | May prolong distress in children with persistent dysphoria; criticized in contemporary practice | low | Desistance rates in historical samples may not generalize to contemporary referrals |
| Social transition in prepubertal children | Observational cohorts (TransYouth Project, Olson; UK and Dutch series) | Short-term improvement in depression and anxiety in some samples | Possible psychological entrenchment; unclear effect on persistence; reversal can be distressing | very_low | High-quality comparative evidence is lacking; effects on long-term trajectory unresolved |
| Treatment of comorbid mood, anxiety, OCD, ADHD | Disorder-specific pediatric evidence base | Standard benefits of established treatments | Standard adverse effects of pediatric psychotropics and psychotherapies | moderate | Comorbidity is treated on its own terms, not as a proxy for gender dysphoria |
| Gender-identity change efforts ("conversion" practices) | Retrospective surveys, advocacy data | None demonstrated | Associated with increased depression, suicidality, and substance use in retrospective samples | low | Not recommended by major guidelines; increasingly prohibited by law |
| Puberty suppression and gender-affirming hormones | Not applicable in prepubertal children | N/A | N/A | not applicable | Considered only at Tanner stage 2 or later; covered in adolescent-focused references |
Harms in this area arise less from specific interventions than from premature certainty in either direction: aggressive medicalization of a child whose dysphoria would have resolved, and dismissive non-engagement with a child whose dysphoria is persistent and worsening. The evidence base supporting prepubertal interventions is dominated by observational data with significant methodologic limitations.
Common adverse outcomes and harm pathways
- Iatrogenic harms of premature affirmation, including psychological entrenchment of an identity that would otherwise have shifted, are difficult to quantify but plausible.[17,30]
- Iatrogenic harms of non-affirmation or rejection include worsening dysphoria, depression, anxiety, self-harm, and family rupture.[7-8]
- Diagnostic overshadowing in children with co-occurring autism, OCD, or trauma can lead to under-treatment of those conditions when the clinical conversation is dominated by gender.[6,19]
Serious or rare adverse outcomes
- Suicidal behavior and non-suicidal self-injury, including anatomy-directed self-harm, occur in a minority but are catastrophic when they do; they are not predicted reliably by single clinical features.[7-8]
- Severe family conflict can escalate to placement disruption, custody disputes, and runaway behavior, particularly in adolescence; prepubertal warning signs deserve attention.[7]
Monitoring and discontinuation considerations
- Care plans require periodic reassessment as the child approaches puberty; trajectories that appeared stable can shift, and the clinical questions change qualitatively at Tanner stage 2.[21,24]
- Decisions about social transition deserve explicit conversation about what reversal would look like if identity shifts; framing transition as a reversible step rather than an irrevocable declaration matters for both child and family.[29-30]
Limitations of the evidence base
- Most prepubertal follow-up cohorts are small, drawn from a handful of specialty clinics, and predate the contemporary referral pattern; generalization to today's clinic population is limited.[16-17]
- Comparative effectiveness data on watchful waiting versus social transition versus other psychosocial approaches in prepubertal children are essentially absent; randomized trials are unlikely on ethical and feasibility grounds.[30]
- Outcome measures vary across studies (identity persistence, mental-health scores, parent-reported functioning, child self-report) and follow-up durations are heterogeneous.[30]
- Several national reviews — notably the Cass Review in the United Kingdom (2024) and the Swedish and Finnish authority reviews — have concluded that the evidence base for both psychosocial and medical interventions in minors is of low certainty overall.[31-32]
Several subgroups require modifications to the assessment and care framework, either because the differential weighting changes or because additional safety considerations apply.
Children with autism spectrum disorder
- Co-occurring ASD is overrepresented; the assessment should explicitly consider how restricted interests, rigid cognition, and atypical social communication influence the presentation of gender-related claims.[6]
- Care plans benefit from clinicians experienced in both ASD and gender dysphoria, and from longer assessment timelines before significant social-environmental changes.[6]
Children with disorders of sex development
- Children with congenital adrenal hyperplasia, partial androgen insensitivity, or other DSD conditions require coordinated care with pediatric endocrinology and surgery teams; the DSM-5-TR specifier applies.[9,13]
- Gender-assignment decisions in infancy and gender-identity outcomes in childhood are distinct questions; both involve substantial uncertainty and have shifted considerably in recent decades.[9]
Children in the foster care or child-welfare system:
- Care planning should account for placement instability, fragmented health records, and consent complexities; these children are at elevated risk for both under- and over-diagnosis.[7,21]
Cultural and religious considerations
- Family, community, and religious contexts shape what gender variance means and what responses are available; effective care engages these systems rather than dismissing them.[21]
- In jurisdictions with legal or social prohibitions on gender-related health care for minors, clinicians have ethical obligations to provide accurate information about risks and benefits while complying with local law.[21,28]
The most-quoted statistic in this area — that the majority of prepubertal children with gender dysphoria do not persist in dysphoria into adolescence — derives from a small number of follow-up cohorts that may not generalize to contemporary referrals. The honest answer is that individual trajectory cannot be predicted reliably.
Persistence and desistance
- Historical follow-up samples reported persistence rates ranging from roughly 12% to 39% across studies, with substantial variation by inclusion criteria, diagnostic threshold, and follow-up age.[16-17]
- Children with more intense, persistent, and consistent identity claims, anatomic dysphoria, and onset closer to puberty are more likely to continue to experience dysphoria into adolescence.[15,17]
- A proportion of children whose dysphoria resolves go on to report sexual-minority orientation in adolescence and adulthood; this association is observed across multiple cohorts.[16-17]
Mental health outcomes
- Depression, anxiety, and self-harm rates in prepubertal children with gender dysphoria are elevated relative to peers but lower than in adolescent samples; the peripubertal period is the highest-risk window.[7-8]
- Family support, school environment, and access to mental-health care are consistently associated with better outcomes in observational studies; whether the relationship is causal at the level of any specific intervention is less certain.[7,30]
Functional outcomes
- Functional impairment in school and peer domains in prepubertal years is variable and tracks with severity of dysphoria, comorbidity, and family climate rather than with identity claims per se.[15,21]
Acute presentations in prepubertal children with gender dysphoria are uncommon but consequential, and they typically reflect comorbid psychiatric illness, family crisis, or anatomy-directed self-harm rather than gender dysphoria as such.
Hospitalization indications
- Acute suicidality, severe self-harm, or anatomy-directed self-injury warrant inpatient psychiatric admission under standard pediatric criteria, with care to use the child's preferred name and pronouns where consistent with the established care plan.[7-8]
- Severe family crisis with imminent placement disruption or violence may require involvement of child protective services or temporary placement.[21]
Suicide and self-harm risk markers
- Established adolescent risk markers apply with caution in prepubertal children: prior attempts, active ideation with plan, hopelessness, severe family rejection, bullying victimization, and limited social support.[7-8]
- Anatomy-directed self-harm in a young child is a specific concern and an indication for urgent assessment.[7]
Agitation management
- Acute agitation is managed using standard pediatric protocols emphasizing environmental de-escalation, family involvement where safe, and minimum effective sedation when necessary; gender-related cues (clothing, room, pronoun use) are clinically relevant aspects of the environment.[21]
Few topics in contemporary psychiatry generate as much disagreement as the care of gender-diverse prepubertal children, and the disagreement is not merely ideological but reflects genuine gaps in the evidence base. The clinician's task is to distinguish areas of professional consensus from areas of active controversy.
Persistence versus desistance
- Older clinic-based cohorts reported that the majority of prepubertal children with gender dysphoria did not persist into adolescent transgender identification, though estimates ranged from roughly 60% to over 85% desistance depending on inclusion criteria and follow-up length.[7-8]
- These studies have been criticized for combining children who met full DSM criteria with subthreshold cases, for high loss to follow-up, and for predating widespread acceptance of transgender identity and social transition as a clinical option.[6,21]
- Newer cohorts including socially transitioned children appear to show higher persistence, though follow-up beyond mid-adolescence is limited and selection effects are difficult to exclude.[15,21]
- The honest summary is that current data do not allow accurate individual-level prediction of persistence in a prepubertal child.[1,6]
Social transition as an intervention
- Whether social transition is best framed as a neutral exploration, a therapeutic intervention, or an action with its own developmental effects is contested among clinicians and guideline bodies.[15,21-22]
- 8 endorses social transition as a reversible option for children when clinically indicated, while emphasizing involvement of an experienced multidisciplinary team.[1]
- Several European systematic reviews and national bodies, including the Cass Review in England, have called for caution given the limited evidence on long-term psychological outcomes and the possibility that social transition affects subsequent trajectory.[21-22]
- Clinicians should present social transition as a serious decision with reversible mechanics but real psychological weight, not as a casual experiment or a foregone conclusion.[1,22]
Therapeutic stance and the rejection of conversion approaches:
- There is broad professional consensus, codified by the APA, AACAP, WPATH, and major medical bodies, that interventions aiming to change a child's gender identity to align with sex assigned at birth are unethical and associated with harm.[1-2,23]
- Disagreement remains about how to characterize developmentally exploratory or watchful-waiting approaches, which proponents distinguish sharply from conversion practices and critics sometimes conflate with them.[21-22]
- Several jurisdictions have enacted statutes regulating clinical practice in this area, in both restrictive and protective directions, and clinicians must work within their local legal frameworks while maintaining professional standards.[1,22]
Evidence quality and the puberty suppression debate:
- Puberty suppression is not used in prepubertal children, but decisions made in childhood about social transition and assessment trajectories feed directly into adolescent decisions about puberty blockade, which has itself been the subject of intense recent review.[1,21-22]
- The Cass Review (England, 2024), reviews commissioned in Sweden, Finland, and Norway, and a 2023 systematic review program have all concluded that the evidence base for adolescent medical interventions is of low to very low certainty.[21-22]
- Other bodies, including WPATH and the Endocrine Society, maintain that the evidence is sufficient to support carefully selected interventions in adolescents and that withholding care also carries risk.[1,3]
- The clinician working with prepubertal children should be transparent with families that the pathway ahead involves contested decisions with imperfect evidence on both sides.[1,21-22]
Autism, neurodivergence, and gender
- The robust association between autism spectrum conditions and gender diversity in referred populations has been replicated but remains incompletely understood mechanistically.[12,19]
- Concerns have been raised that autistic children may have specific assessment needs and that their experience of gender may be qualitatively distinct, though the data remain limited.[12,19,22]
- Best practice involves screening for autism in all referred children and ensuring that assessment is developmentally appropriate, without assuming that autism either explains away or invalidates the experience of gender dysphoria.[12,19]
Research priorities and the role of registries:
- High-quality prospective cohort studies with rigorous psychosocial outcome measurement and long follow-up are urgently needed and are now being established in several countries.[21-22]
- Randomized trials of psychosocial interventions are feasible and underused; trials of social transition are ethically and practically more complex.[21-22]
- Clinicians and families navigating this area today are operating ahead of the evidence and should be told so plainly.[1,21-22]
- DSM-5-TR places gender dysphoria in its own chapter, separate from sexual dysfunctions and paraphilic disorders, and provides distinct criterion sets for children versus adolescents and adults.[2]
- The diagnosis in children requires at least 6 of 8 criteria, and the first criterion (a strong desire to be, or insistence that one is, the other gender) is mandatory; duration is at least 6 months.[2]
- DSM-5-TR requires clinically significant distress or functional impairment; gender variance alone is not a disorder.[2]
- ICD-11 reclassified the condition as Gender Incongruence and moved it out of the mental disorders chapter into Conditions Related to Sexual Health.[4]
- Older clinic-based cohorts found that most prepubertal children with gender dysphoria did not persist into adolescent transgender identification, though estimates and methods are contested.[7-8]
- Strong predictors of persistence include greater intensity and consistency of cross-gender identification, verbal statements of being the other gender rather than wishing to be, and persistence into early adolescence.[6,8]
- Prepubertal children with gender dysphoria show elevated rates of anxiety disorders, depression, and autism spectrum disorder relative to community samples.[5-6,12]
- The 46,XX child with congenital adrenal hyperplasia and prenatal androgen exposure shows increased cross-gender behavior but most do not develop gender dysphoria, illustrating the dissociation between behavior and identity.[11]
- Puberty suppression with GnRH analogues is not used in prepubertal children; eligibility requires Tanner stage 2 or higher.[1,3]
- Psychotropic medication has no role in treating gender dysphoria itself; pharmacotherapy targets comorbid conditions only.[1-2]
- Conversion or reparative approaches aimed at changing gender identity are considered unethical and harmful by major professional bodies.[1-2,23]
- Social transition in prepubertal children is mechanically reversible but psychologically consequential and should involve careful multidisciplinary discussion.[1,22]
- Suicide risk in gender-diverse youth is elevated compared with peers, driven substantially by minority stress, family rejection, and bullying.[24,26]
- Family acceptance is one of the most consistent predictors of better mental health outcomes in gender-diverse youth.[24,26]
- Validated assessment instruments in this population include the Gender Identity Interview for Children and the Utrecht Gender Dysphoria Scale; broad psychiatric assessment and autism screening are mandatory adjuncts.[13-14]
No external funding. No conflicts of interest declared. Peer-review status: pending.
- 1.Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-S259. doi:10.1080/26895269.2022.2100644.doi:10.1080/26895269.2022.2100644.
- 2.TextbookAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text rev. Washington, DC: American Psychiatric Association Publishing; 2022.
- 3.GuidelineHembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. doi:10.1210/jc.2017-01658.doi:10.1210/jc.2017-01658.
- 4.TextbookWorld Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: World Health Organization; 2019.
- 5.Zucker KJ. Epidemiology of gender dysphoria and transgender identity. Sex Health. 2017;14(5):404-411. doi:10.1071/SH17067.doi:10.1071/SH17067.
- 6.Steensma TD, Kreukels BPC, de Vries ALC, Cohen-Kettenis PT. Gender identity development in adolescence. Horm Behav. 2013;64(2):288-297. doi:10.1016/j.yhbeh.2013.02.020.doi:10.1016/j.yhbeh.2013.02.020.
- 7.Wallien MSC, Cohen-Kettenis PT. Psychosexual outcome of gender-dysphoric children. J Am Acad Child Adolesc Psychiatry. 2008;47(12):1413-1423. doi:10.1097/CHI.0b013e31818956b9.doi:10.1097/CHI.0b013e31818956b9.
- 8.Steensma TD, McGuire JK, Kreukels BPC, Beekman AJ, Cohen-Kettenis PT. Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. J Am Acad Child Adolesc Psychiatry. 2013;52(6):582-590. doi:10.1016/j.jaac.2013.03.016.doi:10.1016/j.jaac.2013.03.016.
- 9.Zucker KJ, Lawrence AA, Kreukels BPC. Gender dysphoria in adults. Annu Rev Clin Psychol. 2016;12:217-247. doi:10.1146/annurev-clinpsy-021815-093034.doi:10.1146/annurev-clinpsy-021815-093034.
- 10.Polderman TJC, Kreukels BPC, Irwig MS, et al. The biological contributions to gender identity and gender diversity: bringing data to the table. Behav Genet. 2018;48(2):95-108. doi:10.1007/s10519-018-9889-z.doi:10.1007/s10519-018-9889-z.
- 11.Berenbaum SA, Beltz AM. Sexual differentiation of human behavior: effects of prenatal and pubertal organizational hormones. Front Neuroendocrinol. 2011;32(2):183-200. doi:10.1016/j.yfrne.2011.03.001.doi:10.1016/j.yfrne.2011.03.001.
- 12.Strang JF, Meagher H, Kenworthy L, et al. Initial clinical guidelines for co-occurring autism spectrum disorder and gender dysphoria or incongruence in adolescents. J Clin Child Adolesc Psychol. 2018;47(1):105-115. doi:10.1080/15374416.2016.1228462.doi:10.1080/15374416.2016.1228462.
- 13.Wallien MSC, Quilty LC, Steensma TD, et al. Cross-national replication of the Gender Identity Interview for Children. J Pers Assess. 2009;91(6):545-552. doi:10.1080/00223890903228463.doi:10.1080/00223890903228463.
- 14.Cohen-Kettenis PT, van Goozen SHM. Sex reassignment of adolescent transsexuals: a follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36(2):263-271. doi:10.1097/00004583-199702000-00017.doi:10.1097/00004583-199702000-00017.
- 15.Olson KR, Durwood L, DeMeules M, McLaughlin KA. Mental health of transgender children who are supported in their identities. Pediatrics. 2016;137(3):e20153223. doi:10.1542/peds.2015-3223.doi:10.1542/peds.2015-3223.
- 16.de Vries ALC, McGuire JK, Steensma TD, Wagenaar ECF, Doreleijers TAH, Cohen-Kettenis PT. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014;134(4):696-704. doi:10.1542/peds.2013-2958.doi:10.1542/peds.2013-2958.
- 17.Drescher J, Pula J. Ethical issues raised by the treatment of gender-variant prepubescent children. Hastings Cent Rep. 2014;44 Spec No:S17-S22. doi:10.1002/hast.365.doi:10.1002/hast.365.
- 18.Hidalgo MA, Ehrensaft D, Tishelman AC, et al. The gender affirmative model: what we know and what we aim to learn. Hum Dev. 2013;56(5):285-290. doi:10.1159/000355235.doi:10.1159/000355235.
- 19.de Vries ALC, Noens ILJ, Cohen-Kettenis PT, van Berckelaer-Onnes IA, Doreleijers TA. Autism spectrum disorders in gender dysphoric children and adolescents. J Autism Dev Disord. 2010;40(8):930-936. doi:10.1007/s10803-010-0935-9.doi:10.1007/s10803-010-0935-9.
- 20.GuidelineAmerican Academy of Child and Adolescent Psychiatry. Practice parameter on gay, lesbian, or bisexual sexual orientation, gender nonconformity, and gender discordance in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2012;51(9):957-974. doi:10.1016/j.jaac.2012.07.004.doi:10.1016/j.jaac.2012.07.004.
- 21.Cass H. Independent Review of Gender Identity Services for Children and Young People: Final Report. London: NHS England; 2024.
- 22.National Institute for Health and Care Excellence. Evidence review: Gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria. London: NICE; 2020.
- 23.American Psychological Association. APA Resolution on Gender Identity Change Efforts. Washington, DC: American Psychological Association; 2021.
- 24.Russell ST, Pollitt AM, Li G, Grossman AH. Chosen name use is linked to reduced depressive symptoms, suicidal ideation, and suicidal behavior among transgender youth. J Adolesc Health. 2018;63(4):503-505. doi:10.1016/j.jadohealth.2018.02.003.doi:10.1016/j.jadohealth.2018.02.003.
- 25.Connolly MD, Zervos MJ, Barone CJ 2nd, Johnson CC, Joseph CLM. The mental health of transgender youth: advances in understanding. J Adolesc Health. 2016;59(5):489-495. doi:10.1016/j.jadohealth.2016.06.012.doi:10.1016/j.jadohealth.2016.06.012.
- 26.Ryan C, Russell ST, Huebner D, Diaz R, Sanchez J. Family acceptance in adolescence and the health of LGBT young adults. J Child Adolesc Psychiatr Nurs. 2010;23(4):205-213. doi:10.1111/j.1744-6171.2010.00246.x.doi:10.1111/j.1744-6171.2010.00246.x.
- 27.TextbookHales RE, Yudofsky SC, Roberts LW, eds. The American Psychiatric Publishing Textbook of Psychiatry. 6th ed. Washington, DC: American Psychiatric Publishing; 2014.
- 28.TextbookSadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Wolters Kluwer; 2015.
- 29.Zucker KJ, Wood H, Singh D, Bradley SJ. A developmental, biopsychosocial model for the treatment of children with gender identity disorder. J Homosex. 2012;59(3):369-397. doi:10.1080/00918369.2012.653309.doi:10.1080/00918369.2012.653309.
- 30.Edwards-Leeper L, Spack NP. Psychological evaluation and medical treatment of transgender youth in an interdisciplinary "Gender Management Service" (GeMS) in a major pediatric center. J Homosex. 2012;59(3):321-336. doi:10.1080/00918369.2012.653302.doi:10.1080/00918369.2012.653302.
- 31.Turban JL, Beckwith N, Reisner SL, Keuroghlian AS. Association between recalled exposure to gender identity conversion efforts and psychological distress and suicide attempts among transgender adults. JAMA Psychiatry. 2020;77(1):68-76. doi:10.1001/jamapsychiatry.2019.2285.doi:10.1001/jamapsychiatry.2019.2285.
- 32.TextbookStahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge: Cambridge University Press; 2021.
More on these topics
Gender Dysphoria in Adolescents and Adults
A clinical reference on the DSM-5-TR diagnosis, assessment, and gender-affirming care of gender dysphoria in adolescents and adults, with current controversies.
Gender DysphoriaChild & Adolescent PsychiatryGender Dysphoria in Adolescents and AdultsGender Dysphoria
Clinical reference on gender dysphoria — DSM-5-TR criteria, assessment, gender-affirming care, and controversies for medical students and psychiatry trainees.
Gender DysphoriaChild & Adolescent PsychiatryAutism Spectrum DisorderBulimia Nervosa: Diagnosis, Workup, and Evidence-Based Treatment
A clinical reference on bulimia nervosa covering DSM-5-TR criteria, medical workup, first-line CBT-E and fluoxetine therapy, and high-risk safety considerations.
Bulimia NervosaChild & Adolescent PsychiatryAvoidant/Restrictive Food Intake Disorder (ARFID): Diagnosis, Assessment, and Treatment
A clinical overview of ARFID covering DSM-5-TR criteria, the three-driver phenotype, differential diagnosis from anorexia nervosa, assessment, and treatment.
Feeding and Eating DisordersChild & Adolescent PsychiatryAutism Spectrum DisorderAnorexia Nervosa: Diagnosis, Differential, and Management
A clinical reference on anorexia nervosa: diagnosis, medical complications, evidence-based treatment, and the highest-mortality eating disorder in psychiatry.
Anorexia NervosaChild & Adolescent PsychiatryRumination Disorder: Diagnosis, Differential, and Management
Repeated regurgitation of food not explained by a GI condition — a feeding disorder that crosses pediatrics, eating disorders, and developmental psychiatry.
Feeding and Eating DisordersChild & Adolescent PsychiatryRumination DisorderPica: Diagnosis, Workup, and Management
A clinical reference on pica covering DSM-5-TR criteria, iron-deficiency workup, pregnancy and developmental considerations, and behavioral treatment.
Child & Adolescent PsychiatryFeeding and Eating DisordersPicaEncopresis: Diagnosis, Evaluation, and Treatment in Children
A clinical reference on encopresis in children covering DSM-5-TR criteria, retentive versus nonretentive subtypes, evaluation, and a stepwise disimpaction-maintenance-behavioral treatment plan.
Elimination DisordersChild & Adolescent PsychiatryEncopresis